Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Uncategorized
Page 2
Uncategorized
Random
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Psygen Industries Ltd letter to Health Canada re: SAP
atai Life Sciences Announces First Subject Dosed in Phase 1 Trial of Buccal and IV VLS-01, a Synthetic Form of DMT
atai Life Sciences to Participate in October Investor Events & Host Virtual R&D Day
atai Impact Donates to the Multidisciplinary Association for Psychedelic Studies (MAPS) to Support Pioneering Work in Psychedelic Medicine
atai Life Sciences Announces First Subject Dosed in the Phase 1 IV-to-Subcutaneous Bridging Study of PCN-101 (R-Ketamine)
atai Life Sciences announces FDA Investigational New Drug (IND) Clearance for...
atai Life Sciences launches TryptageniX to further expand atai’s robust intellectual...
Markets for Feb 24: $AION -18.75%, $TRIP +12.64%, $MCUR +11.53%
Markets for Feb 13: $WUHN +34.14%, $PLNT +15.38%, $RVV +14.39%
atai Life Sciences Announces R&D Day Agenda
William Leonard Pickard participating in celebration for Sasha Shulgin’s new book...
atai Life Sciences Has Been Selected for Addition to the NASDAQ...
February’s Psychedelic Capital Investigates Institutional Vs Retail Investor Impact
MindMed Announces Successful Completion of Pre-IND Meeting with the FDA for...
atai Life Sciences Reports First Quarter 2023 Financial Results and Announces...
1
2
3
...
12
Page 2 of 12